{"id":326724,"date":"2019-02-06T17:21:02","date_gmt":"2019-02-06T17:21:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=326724"},"modified":"2019-02-06T17:21:02","modified_gmt":"2019-02-06T17:21:02","slug":"oral-vaccines-market-analysis-by-type-rotavirus-vaccine-cholera-vaccine-polio-vaccine-by-application-infant-children-adults-opportunities-and-forecast-20172022","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/oral-vaccines-market-analysis-by-type-rotavirus-vaccine-cholera-vaccine-polio-vaccine-by-application-infant-children-adults-opportunities-and-forecast-20172022_326724.html","title":{"rendered":"ORAL VACCINES MARKET: ANALYSIS BY TYPE (ROTAVIRUS VACCINE , CHOLERA VACCINE, POLIO VACCINE), BY APPLICATION (INFANT, CHILDREN, ADULTS) : OPPORTUNITIES AND FORECAST (2017-2022)"},"content":{"rendered":"
\"\"<\/a><\/div>\n
Oral vaccine provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities.<\/div>\n

An oral vaccine<\/a> <\/strong><\/em>is one that is taken by mouth, instead of being injected directly into the blood. The goal of all vaccines, whether administered by injection or as an oral vaccine, is to trigger the body’s immune system without the person actually having the disease. It is a way of immunizing, or protecting, the body from getting the disease.<\/p>\n

Scope of the Report:<\/strong>
This report focuses on the Oral Vaccines in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.<\/p>\n

Market Segment by Manufacturers<\/strong>, this report covers
GlaxoSmithKline<\/strong>
PaxVax<\/strong>
Merial<\/strong>
Merck<\/strong>
Sanofi<\/strong>
Crucell<\/strong>
Quimica Suiza<\/strong>
Immunitor<\/strong>
Hualan Biological Engineering<\/strong>
BB-NCIPD<\/strong>
Vaxart<\/strong><\/p>\n

Request a Sample Copy:https:\/\/www.worldwidemarketreports.com\/sample\/2211<\/a>    <\/strong>
<\/strong><\/p>\n

Market Segment by Regions<\/strong>, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)<\/p>\n

Market Segment by Type<\/strong>, covers
Rotavirus Vaccine 
Cholera Vaccine
Polio Vaccine
Others<\/p>\n

Market Segment by Applications<\/strong>, can be divided into
Infant
Children
Adults<\/p>\n

There are 15 Chapters to deeply display the global Oral Vaccines market.<\/strong>
Chapter 1, to describe Oral Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oral Vaccines, with sales, revenue, and price of Oral Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Vaccines, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Oral Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source<\/p>\n

Inquire Before Buying<\/strong>: https:\/\/www.worldwidemarketreports.com\/quiry\/2211<\/a> <\/strong><\/p>\n

Table of Contents<\/strong>
1 Market Overview
2 Manufacturers Profiles
3 Global Oral Vaccines Market Competition, by Manufacturer
4 Global Oral Vaccines Market Analysis by Regions
5 North America Oral Vaccines by Countries
6 Europe Oral Vaccines by Countries
7 Asia-Pacific Oral Vaccines by Countries
8 South America Oral Vaccines by Countries
9 Middle East and Africa Oral Vaccines by Countries
10 Global Oral Vaccines Market Segment by Type
11 Global Oral Vaccines Market Segment by Application
12 Oral Vaccines Market Forecast (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix<\/p>\n

List of Tables and Figures<\/strong>
Figure Oral Vaccines Picture
Table Product Specifications of Oral Vaccines
Figure Global Sales Market Share of Oral Vaccines by Types in 2016
Table Oral Vaccines Types for Major Manufacturers
Figure Rotavirus Vaccine Picture
Figure Cholera Vaccine Picture
Figure Polio Vaccine Picture
Figure Others Picture
Table Oral Vaccines Sales Market Share by Applications in 2016
Figure Infant Picture
Figure Children Picture
Figure Adults Picture
Figure USA Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure France Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure UK Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure China Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure India Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Oral Vaccines Revenue (Value) and Growth Rate (2012-2022)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Oral Vaccines Type and Applications
Table GlaxoSmithKline Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PaxVax Basic Information, Manufacturing Base and Competitors
….Continued<\/strong><\/p>\n

Purchase oral vaccine Market Report at https:\/\/www.worldwidemarketreports.com\/buy\/2211<\/a> <\/strong><\/strong><\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Worldwide Market Reports
Contact Person:<\/strong> Mr. Shah
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1-206-701-6702
Address:<\/strong>1001 4th Ave, #3200
City:<\/strong> Seattle
State:<\/strong> Washington
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.worldwidemarketreports.com\/speakanalyst\/2211<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Oral vaccine provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities. An oral vaccine is one that is taken by mouth, instead of being injected directly into the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-326724","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/326724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=326724"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/326724\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=326724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=326724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=326724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}